{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T12:09:13Z","timestamp":1788610153617,"version":"build-2803163510"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-28395-7","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T13:43:41Z","timestamp":1767015821000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Genomic analysis unlocks the potential of denosumab as a targeted therapy for Crohn\u2019s disease"],"prefix":"10.1038","volume":"15","author":[{"given":"Rio","family":"Pranata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neneng","family":"Ratnasari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Putut","family":"Bayupurnama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahmi","family":"Indrarti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisma","family":"Aulia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hegaria","family":"Rahmawati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wirawan","family":"Adikusuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eko","family":"Mugiyanto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lalu Muhammad","family":"Irham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Gunarto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salma Shabira","family":"Alya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa Felicia","family":"Hadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisella Chika","family":"Sentosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arum Tri","family":"Wahyuningsih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiou-Feng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahmat Dani","family":"Satria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"key":"28395_CR1","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/S0140-6736(23)02586-2","volume":"403","author":"M Dolinger","year":"2024","unstructured":"Dolinger, M., Torres, J. & Vermeire, S. Crohn\u2019s disease. Lancet 403, 1177\u20131191 (2024).","journal-title":"Lancet"},{"key":"28395_CR2","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.3390\/life13102062","volume":"13","author":"G Pasternak","year":"2023","unstructured":"Pasternak, G. et al. Crohn\u2019s disease: basic characteristics of the Disease, diagnostic Methods, the role of Biomarkers, and analysis of metalloproteinases: A review. Life 13, 2062 (2023).","journal-title":"Life"},{"key":"28395_CR3","doi-asserted-by":"publisher","first-page":"549","DOI":"10.7861\/clinmed.2023-0493","volume":"23","author":"E Cockburn","year":"2023","unstructured":"Cockburn, E. et al. Crohn\u2019s disease: an update. Clin. Med. 23, 549\u2013557 (2023).","journal-title":"Clin. Med."},{"key":"28395_CR4","doi-asserted-by":"publisher","first-page":"e34817","DOI":"10.1097\/MD.0000000000034817","volume":"102","author":"A Karabulut","year":"2023","unstructured":"Karabulut, A. & Kaya, M. Crohn\u2019s disease from past to present: research trends and global outcomes with scientometric analysis during 1980 to 2022. Medicine 102, e34817 (2023).","journal-title":"Medicine"},{"key":"28395_CR5","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1001\/jama.2020.18936","volume":"325","author":"K Cushing","year":"2021","unstructured":"Cushing, K. & Higgins, P. D. R. Management of Crohn disease. JAMA 325, 69 (2021).","journal-title":"JAMA"},{"key":"28395_CR6","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1093\/ecco-jcc\/jjae091","volume":"18","author":"H Gordon","year":"2024","unstructured":"Gordon, H. et al. ECCO guidelines on therapeutics in crohn\u2019s disease: medical treatment. J. Crohns Colitis. 18, 1531\u20131555 (2024).","journal-title":"J. Crohns Colitis"},{"key":"28395_CR7","doi-asserted-by":"publisher","first-page":"7491","DOI":"10.7150\/thno.59196","volume":"11","author":"Z Wang","year":"2021","unstructured":"Wang, Z. et al. Microbial and genetic-based framework identifies drug targets in inflammatory bowel disease. Theranostics 11, 7491\u20137506 (2021).","journal-title":"Theranostics"},{"key":"28395_CR8","doi-asserted-by":"publisher","first-page":"5595","DOI":"10.3390\/jcm12175595","volume":"12","author":"KM Scheurlen","year":"2023","unstructured":"Scheurlen, K. M., Parks, M. A., Macleod, A. & Galandiuk, S. Unmet challenges in patients with crohn\u2019s disease. J. Clin. Med. 12, 5595 (2023).","journal-title":"J. Clin. Med."},{"key":"28395_CR9","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1001\/jama.2013.4466","volume":"309","author":"AS Cheifetz","year":"2018","unstructured":"Cheifetz, A. S. Management of active Crohn disease. JAMA 309, 2150 (2018).","journal-title":"JAMA"},{"key":"28395_CR10","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.csbj.2019.01.001","volume":"17","author":"L Grenier","year":"2019","unstructured":"Grenier, L. & Hu, P. Computational drug repurposing for inflammatory bowel disease using genetic information. Comput. Struct. Biotechnol. J. 17, 127\u2013135 (2019).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"28395_CR11","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s12864-022-08491-y","volume":"23","author":"D Garza-Hernandez","year":"2022","unstructured":"Garza-Hernandez, D. et al. A systematic review and functional bioinformatics analysis of genes associated with crohn\u2019s disease identify more than 120 related genes. BMC Genom. 23, 302 (2022).","journal-title":"BMC Genom."},{"key":"28395_CR12","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1038\/s41588-023-01422-x","volume":"55","author":"K Kiryluk","year":"2023","unstructured":"Kiryluk, K. et al. Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy. Nat. Genet. 55, 1091\u20131105 (2023).","journal-title":"Nat. Genet."},{"key":"28395_CR13","doi-asserted-by":"publisher","first-page":"100306","DOI":"10.1016\/j.xgen.2023.100306","volume":"3","author":"AC Brown","year":"2023","unstructured":"Brown, A. C. et al. Comprehensive epigenomic profiling reveals the extent of disease-specific chromatin States and informs target discovery in ankylosing spondylitis. Cell. Genomics. 3, 100306 (2023).","journal-title":"Cell. Genomics"},{"key":"28395_CR14","doi-asserted-by":"publisher","first-page":"D1358","DOI":"10.1093\/nar\/gkab994","volume":"50","author":"H Fang","year":"2022","unstructured":"Fang, H. & Knight, J. C. Priority index: database of genetic targets in immune-mediated disease. Nucleic Acids Res. 50, D1358\u2013D1367 (2022).","journal-title":"Nucleic Acids Res."},{"key":"28395_CR15","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1038\/s41588-019-0456-1","volume":"51","author":"H Fang","year":"2019","unstructured":"Fang, H. et al. A genetics-led approach defines the drug target landscape of 30 immune-related traits. Nat. Genet. 51, 1082\u20131091 (2019).","journal-title":"Nat. Genet."},{"key":"28395_CR16","doi-asserted-by":"publisher","first-page":"D1467","DOI":"10.1093\/nar\/gkae1128","volume":"53","author":"A Buniello","year":"2025","unstructured":"Buniello, A. et al. Open targets platform: facilitating therapeutic hypotheses Building in drug discovery. Nucleic Acids Res. 53, D1467\u2013D1475 (2025).","journal-title":"Nucleic Acids Res."},{"key":"28395_CR17","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.5808\/gi.23011","volume":"21","author":"RD Satria","year":"2023","unstructured":"Satria, R. D. et al. Identification of druggable genes for multiple myeloma based on genomic information. Genomics Inf. 21, e31 (2023).","journal-title":"Genomics Inf."},{"key":"28395_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s44342-025-00047-2","volume":"23","author":"U Sukorini","year":"2025","unstructured":"Sukorini, U. et al. Genome-wide association study-driven identification of thrombomodulin and factor V as the best biomarker combination for deep vein thrombosis. Genomics Inf. 23, 11 (2025).","journal-title":"Genomics Inf."},{"key":"28395_CR19","doi-asserted-by":"publisher","first-page":"100502","DOI":"10.1016\/j.jgeb.2025.100502","volume":"23","author":"RD Satria","year":"2025","unstructured":"Satria, R. D. et al. Genome-wide association study\u2009\u2013\u2009Driven drug repositioning for the treatment of insomnia. J. Genetic Eng. Biotechnol. 23, 100502 (2025).","journal-title":"J. Genetic Eng. Biotechnol."},{"key":"28395_CR20","doi-asserted-by":"publisher","first-page":"21688","DOI":"10.1038\/s41598-025-02848-5","volume":"15","author":"RD Satria","year":"2025","unstructured":"Satria, R. D. et al. Bioinformatic and genomic analysis identifies C allele of APOE rs7412 as the most prominent variant limiting extreme human longevity. Sci. Rep. 15, 21688 (2025).","journal-title":"Sci. Rep."},{"key":"28395_CR21","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nature12873","volume":"506","author":"Y Okada","year":"2014","unstructured":"Okada, Y. et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 506, 376\u2013381 (2014).","journal-title":"Nature"},{"key":"28395_CR22","first-page":"101334","volume":"32","author":"LM Irham","year":"2022","unstructured":"Irham, L. M., Adikusuma, W. & Perwitasari, D. A. Genomic variants-driven drug repurposing for tuberculosis by utilizing the established bioinformatic-based approach. Biochem. Biophys. Rep. 32, 101334 (2022).","journal-title":"Biochem. Biophys. Rep."},{"key":"28395_CR23","doi-asserted-by":"publisher","first-page":"10032","DOI":"10.1038\/s41598-023-37120-1","volume":"13","author":"W Adikusuma","year":"2023","unstructured":"Adikusuma, W. et al. Transcriptomics-driven drug repositioning for the treatment of diabetic foot ulcer. Sci. Rep. 13, 10032 (2023).","journal-title":"Sci. Rep."},{"key":"28395_CR24","doi-asserted-by":"publisher","first-page":"101831","DOI":"10.1016\/j.jsps.2023.101831","volume":"31","author":"W Adikusuma","year":"2023","unstructured":"Adikusuma, W. et al. Integrated genomic network analysis revealed potential of a druggable target for hemorrhoid treatment. Saudi Pharm. J. 31, 101831 (2023).","journal-title":"Saudi Pharm. J."},{"key":"28395_CR25","doi-asserted-by":"publisher","first-page":"D1144","DOI":"10.1093\/nar\/gkaa1084","volume":"49","author":"SL Freshour","year":"2021","unstructured":"Freshour, S. L. et al. Integration of the Drug-Gene interaction database (DGIdb 4.0) with open crowdsource efforts. Nucleic Acids Res. 49, D1144\u2013D1151 (2021).","journal-title":"Nucleic Acids Res."},{"key":"28395_CR26","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/nature11582","volume":"491","author":"L Jostins","year":"2012","unstructured":"Jostins, L. et al. Host\u2013microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491, 119\u2013124 (2012).","journal-title":"Nature"},{"key":"28395_CR27","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nature10209","volume":"474","author":"B Khor","year":"2011","unstructured":"Khor, B., Gardet, A. & Xavier, R. J. Genetics and pathogenesis of inflammatory bowel disease. Nature 474, 307\u2013317 (2011).","journal-title":"Nature"},{"key":"28395_CR28","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/35079107","volume":"411","author":"JP Hugot","year":"2001","unstructured":"Hugot, J. P. et al. Association of NOD2 leucine-rich repeat variants with susceptibility to crohn\u2019s disease. Nature 411, 599\u2013603 (2001).","journal-title":"Nature"},{"key":"28395_CR29","doi-asserted-by":"publisher","first-page":"4775","DOI":"10.3390\/ijms26104775","volume":"26","author":"P Pastras","year":"2025","unstructured":"Pastras, P., Aggeletopoulou, I., Papantoniou, K. & Triantos, C. Targeting the IL-23 receptor gene: A promising approach in inflammatory bowel disease treatment. Int. J. Mol. Sci. 26, 4775 (2025).","journal-title":"Int. J. Mol. Sci."},{"key":"28395_CR30","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1093\/ibd\/izac205","volume":"29","author":"JJ Ashton","year":"2023","unstructured":"Ashton, J. J. et al. Prediction of Crohn\u2019s Disease Stricturing Phenotype Using a NOD2- derived Genomic Biomarker. Inflamm. Bowel Dis. 29, 511\u2013521 (2023).","journal-title":"Inflamm. Bowel Dis."},{"key":"28395_CR31","doi-asserted-by":"crossref","unstructured":"Samad, M. A. et al. STAT3 signaling pathway in health and disease. MedComm (Beijing) 6, (2025).","DOI":"10.1002\/mco2.70152"},{"key":"28395_CR32","doi-asserted-by":"publisher","first-page":"7020","DOI":"10.3390\/jcm11237020","volume":"11","author":"P Robinson","year":"2022","unstructured":"Robinson, P. et al. Genetic and Small-Molecule modulation of Stat3 in a mouse model of crohn\u2019s disease. J. Clin. Med. 11, 7020 (2022).","journal-title":"J. Clin. Med."},{"key":"28395_CR33","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1002\/jbmr.3703","volume":"34","author":"HF Lu","year":"2019","unstructured":"Lu, H. F. et al. Meta-Analysis of Genome-Wide association studies identifies three loci associated with stiffness index of the calcaneus. J. Bone Miner. Res. 34, 1275\u20131283 (2019).","journal-title":"J. Bone Miner. Res."},{"key":"28395_CR34","doi-asserted-by":"publisher","first-page":"W305","DOI":"10.1093\/nar\/gkp427","volume":"37","author":"J Chen","year":"2009","unstructured":"Chen, J., Bardes, E. E., Aronow, B. J. & Jegga, A. G. ToppGene suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Res. 37, W305\u2013W311 (2009).","journal-title":"Nucleic Acids Res."},{"key":"28395_CR35","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/j.1744-313X.2005.00546.x","volume":"32","author":"MEA Borm","year":"2005","unstructured":"Borm, M. E. A., van Bodegraven, A. A., Mulder, C. J. J., Kraal, G. & Bouma, G. A NFKB1 promoter polymorphism is involved in susceptibility to ulcerative colitis. Int. J. Immunogenet. 32, 401\u2013405 (2005).","journal-title":"Int. J. Immunogenet."},{"key":"28395_CR36","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1038\/ng.175","volume":"40","author":"JC Barrett","year":"2008","unstructured":"Barrett, J. C. et al. Genome-wide association defines more than 30 distinct susceptibility loci for crohn\u2019s disease. Nat. Genet. 40, 955\u2013962 (2008).","journal-title":"Nat. Genet."},{"key":"28395_CR37","doi-asserted-by":"crossref","unstructured":"Bouwman, W., Verhaegh, W. & van de Stolpe, A. Improved diagnosis of inflammatory bowel disease and prediction and monitoring of response to anti-TNF alpha treatment based on measurement of signal transduction pathway activity. Front Pharmacol 13, (2022).","DOI":"10.3389\/fphar.2022.1008976"},{"key":"28395_CR38","doi-asserted-by":"publisher","first-page":"e202302394","DOI":"10.26508\/lsa.202302394","volume":"7","author":"H Liu","year":"2024","unstructured":"Liu, H. et al. A broken network of susceptibility genes in the monocytes of crohn\u2019s disease patients. Life Sci. Alliance. 7, e202302394 (2024).","journal-title":"Life Sci. Alliance"},{"key":"28395_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3897\/pharmacia.72.e146759","volume":"72","author":"M Moneva-Sakelarieva","year":"2025","unstructured":"Moneva-Sakelarieva, M. et al. The role of the transcription factor NF-kB in the pathogenesis of inflammation and carcinogenesis. Modulation capabilities. Pharmacia 72, 1\u201313 (2025).","journal-title":"Pharmacia"},{"key":"28395_CR40","doi-asserted-by":"publisher","first-page":"9453","DOI":"10.1073\/pnas.1821068116","volume":"116","author":"Z Ji","year":"2019","unstructured":"Ji, Z., He, L., Regev, A. & Struhl, K. Inflammatory regulatory network mediated by the joint action of NF-kB, STAT3, and AP-1 factors is involved in many human cancers. Proc. Natl. Acad. Sci. 116, 9453\u20139462 (2019).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"28395_CR41","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","volume":"9","author":"Q Guo","year":"2024","unstructured":"Guo, Q. et al. NF-\u03baB in biology and targeted therapy: new insights and translational implications. Signal. Transduct. Target. Ther. 9, 53 (2024).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"28395_CR42","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/s41588-023-01384-0","volume":"55","author":"Z Liu","year":"2023","unstructured":"Liu, Z. et al. Genetic architecture of the inflammatory bowel diseases across East Asian and European ancestries. Nat. Genet. 55, 796\u2013806 (2023).","journal-title":"Nat. Genet."},{"key":"28395_CR43","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/ng.3760","volume":"49","author":"KM de Lange","year":"2017","unstructured":"de Lange, K. M. et al. Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease. Nat. Genet. 49, 256\u2013261 (2017).","journal-title":"Nat. Genet."},{"key":"28395_CR44","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s40291-023-00678-7","volume":"28","author":"J El Hadad","year":"2024","unstructured":"El Hadad, J., Schreiner, P., Vavricka, S. R. & Greuter, T. The genetics of inflammatory bowel disease. Mol. Diagn. Ther. 28, 27\u201335 (2024).","journal-title":"Mol. Diagn. Ther."},{"key":"28395_CR45","doi-asserted-by":"crossref","unstructured":"Huang, R. et al. Identifying immune cell infiltration and effective diagnostic biomarkers in crohn\u2019s disease by bioinformatics analysis. Front Immunol 14, (2023).","DOI":"10.3389\/fimmu.2023.1162473"},{"key":"28395_CR46","doi-asserted-by":"crossref","unstructured":"Nguyen, V. Q. et al. Noncanonical NF-\u03baB signaling upregulation in inflammatory bowel disease patients is associated with loss of response to Anti-TNF agents. Front Pharmacol 12, (2021).","DOI":"10.3389\/fphar.2021.655887"},{"key":"28395_CR47","doi-asserted-by":"publisher","first-page":"113633","DOI":"10.1016\/j.ejmech.2021.113633","volume":"223","author":"H Jiang","year":"2021","unstructured":"Jiang, H. et al. Application of carbohydrates in approved small molecule drugs: A review. Eur. J. Med. Chem. 223, 113633 (2021).","journal-title":"Eur. J. Med. Chem."},{"key":"28395_CR48","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s12325-021-01936-y","volume":"39","author":"DL Kendler","year":"2022","unstructured":"Kendler, D. L., Cosman, F., Stad, R. K. & Ferrari, S. Denosumab in the treatment of osteoporosis: 10 years later: A narrative review. Adv. Ther. 39, 58\u201374 (2022).","journal-title":"Adv. Ther."},{"key":"28395_CR49","doi-asserted-by":"publisher","first-page":"106872","DOI":"10.1016\/j.intimp.2020.106872","volume":"88","author":"HY Kim","year":"2020","unstructured":"Kim, H. Y., Kang, H. G., Nam, S. Y., Kim, H. M. & Jeong, H. J. Blockade of RANKL\/RANK signaling pathway by Epigallocatechin gallate alleviates mast cell-mediated inflammatory reactions. Int. Immunopharmacol. 88, 106872 (2020).","journal-title":"Int. Immunopharmacol."},{"key":"28395_CR50","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1080\/1744666X.2021.1971972","volume":"17","author":"A Lleo","year":"2021","unstructured":"Lleo, A. & Gershwin, M. E. Targeting the RANK\/RANKL pathway in autoimmune disease and malignancy: future perspectives. Expert Rev. Clin. Immunol. 17, 933\u2013936 (2021).","journal-title":"Expert Rev. Clin. Immunol."},{"key":"28395_CR51","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/s41423-025-01310-w","volume":"22","author":"H Mao","year":"2025","unstructured":"Mao, H., Zhao, X. & Sun, S. C. NF-\u03baB in inflammation and cancer. Cell. Mol. Immunol. 22, 811\u2013839 (2025).","journal-title":"Cell. Mol. Immunol."},{"key":"28395_CR52","doi-asserted-by":"crossref","unstructured":"Pagnini, C. & Cominelli, F. Tumor necrosis factor\u2019s pathway in crohn\u2019s disease: potential for intervention. Int J. Mol. Sci 22, (2021).","DOI":"10.3390\/ijms221910273"},{"key":"28395_CR53","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1152\/physrev.00045.2017","volume":"99","author":"C Dostert","year":"2019","unstructured":"Dostert, C., Grusdat, M., Letellier, E. & Brenner, D. The TNF family of ligands and receptors: communication modules in the immune system and beyond. Physiol. Rev. 99, 115\u2013160 (2019).","journal-title":"Physiol. Rev."},{"key":"28395_CR54","doi-asserted-by":"crossref","unstructured":"Khafipour, A. et al. Denosumab regulates gut microbiota composition and cytokines in dinitrobenzene sulfonic acid (DNBS)-Experimental colitis. Front Microbiol 11, (2020).","DOI":"10.3389\/fmicb.2020.01405"},{"key":"28395_CR55","unstructured":"Ranasinghe, I. R., Tian, C., Ronald & Affiliations, H. Crohn Disease."},{"key":"28395_CR56","doi-asserted-by":"publisher","unstructured":"Petagna, L. et al. Pathophysiology of Crohn\u2019s disease inflammation and recurrence. Biology Direct vol. 15 Preprint at (2020). https:\/\/doi.org\/10.1186\/s13062-020-00280-5","DOI":"10.1186\/s13062-020-00280-5"},{"key":"28395_CR57","doi-asserted-by":"crossref","unstructured":"Li, Y. et al. Inflammation-fibrosis interplay in inflammatory bowel disease: mechanisms, progression, and therapeutic strategies. Front Pharmacol 16, (2025).","DOI":"10.3389\/fphar.2025.1530797"},{"key":"28395_CR58","doi-asserted-by":"crossref","unstructured":"Albert-Bayo, M. et al. Intestinal Mucosal Mast Cells: Key Modulators of Barrier Function and Homeostasis. Cells 8, (2019).","DOI":"10.3390\/cells8020135"},{"key":"28395_CR59","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ejphar.2016.02.018","volume":"778","author":"SC Bischoff","year":"2016","unstructured":"Bischoff, S. C. Mast cells in Gastrointestinal disorders. Eur. J. Pharmacol. 778, 139\u2013145 (2016).","journal-title":"Eur. J. Pharmacol."},{"key":"28395_CR60","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1111\/j.1440-1746.2007.05011.x","volume":"22","author":"A Farhadi","year":"2007","unstructured":"Farhadi, A. et al. Reduced immunostaining for c-kit receptors in mucosal mast cells in inflammatory bowel disease. J. Gastroenterol. Hepatol. 22, 2338\u20132343 (2007).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"28395_CR61","doi-asserted-by":"crossref","unstructured":"Noto, C. N., Hoft, S. G. & DiPaolo, R. J. Mast cells as important regulators in autoimmunity and cancer development. Front Cell. Dev. Biol 9, (2021).","DOI":"10.3389\/fcell.2021.752350"},{"key":"28395_CR62","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jaci.2024.05.025","volume":"154","author":"M Castells","year":"2024","unstructured":"Castells, M. et al. Mast cell activation syndrome: current Understanding and research needs. J. Allergy Clin. Immunol. 154, 255\u2013263 (2024).","journal-title":"J. Allergy Clin. Immunol."},{"key":"28395_CR63","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/s41467-024-45057-w","volume":"15","author":"C von Beek","year":"2024","unstructured":"von Beek, C. et al. A two-step activation mechanism enables mast cells to differentiate their response between extracellular and invasive enterobacterial infection. Nat. Commun. 15, 904 (2024).","journal-title":"Nat. Commun."},{"key":"28395_CR64","doi-asserted-by":"crossref","unstructured":"Draberova, L., Tumova, M. & Draber, P. Molecular mechanisms of mast cell activation by Cholesterol-Dependent cytolysins. Front Immunol 12, (2021).","DOI":"10.3389\/fimmu.2021.670205"},{"key":"28395_CR65","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s12664-020-01114-y","volume":"40","author":"JSY Tam","year":"2021","unstructured":"Tam, J. S. Y., Coller, J. K., Hughes, P. A., Prestidge, C. A. & Bowen, J. M. Toll-like receptor 4 (TLR4) antagonists as potential therapeutics for intestinal inflammation. Indian J. Gastroenterol. 40, 5\u201321 (2021).","journal-title":"Indian J. Gastroenterol."},{"key":"28395_CR66","doi-asserted-by":"publisher","unstructured":"Stidham, R. W. et al. Systematic review with network meta-analysis: The efficacy of anti-TNF agents for the treatment of Crohn\u2019s disease. Alimentary Pharmacology and Therapeutics vol. 39 1349\u20131362 Preprint at (2014). https:\/\/doi.org\/10.1111\/apt.12749","DOI":"10.1111\/apt.12749"},{"key":"28395_CR67","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1111\/apt.13190","volume":"41","author":"L Moja","year":"2015","unstructured":"Moja, L., Danese, S., Fiorino, G., Del Giovane, C. & Bonovas, S. Systematic review with network meta-analysis: comparative efficacy and safety of Budesonide and mesalazine (mesalamine) for crohn\u2019s disease. Aliment. Pharmacol. Ther. 41, 1055\u20131065 (2015).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"28395_CR68","doi-asserted-by":"crossref","unstructured":"Dvornikova, K. A., Platonova, O. N. & Bystrova, E. Y. Inflammatory bowel disease: crosstalk between Histamine, Immunity, and disease. Int J. Mol. Sci 24, (2023).","DOI":"10.3390\/ijms24129937"},{"key":"28395_CR69","doi-asserted-by":"crossref","unstructured":"Becker, J., Ott, D. & Diener, M. Impact of sensitization and inflammation on the interaction of mast cells with the intestinal epithelium in rats. Front Physiol 10, (2019).","DOI":"10.3389\/fphys.2019.00329"},{"key":"28395_CR70","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1136\/gutjnl-2024-334165","volume":"74","author":"V Gudi\u00f1o","year":"2025","unstructured":"Gudi\u00f1o, V., Bartolom\u00e9-Casado, R. & Salas, A. Single-cell omics in inflammatory bowel disease: recent insights and future clinical applications. Gut 74, 1335\u20131345 (2025).","journal-title":"Gut"},{"key":"28395_CR71","unstructured":"National Center for Biotechnology Information (NCBI). TNFSF11 TNF Superfamily Member 11 [ Homo Sapiens (Human) ]. (2025)."},{"key":"28395_CR72","doi-asserted-by":"publisher","first-page":"101780","DOI":"10.1016\/j.xcrm.2024.101780","volume":"5","author":"S Van Remoortel","year":"2024","unstructured":"Van Remoortel, S., Hussein, H. & Boeckxstaens, G. Mast cell modulation: A novel therapeutic strategy for abdominal pain in irritable bowel syndrome. Cell. Rep. Med. 5, 101780 (2024).","journal-title":"Cell. Rep. Med."},{"key":"28395_CR73","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/36593","volume":"390","author":"DM Anderson","year":"1997","unstructured":"Anderson, D. M. et al. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390, 175\u2013179 (1997).","journal-title":"Nature"},{"key":"28395_CR74","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S0969-2126(02)00723-2","volume":"10","author":"CR Escalante","year":"2002","unstructured":"Escalante, C. R., Shen, L., Thanos, D. & Aggarwal, A. K. Structure of NF-\u03baB p50\/p65 heterodimer bound to the PRDII DNA element from the Interferon-\u03b2 promoter. Structure 10, 383\u2013391 (2002).","journal-title":"Structure"},{"key":"28395_CR75","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.4049\/jimmunol.0803637","volume":"182","author":"M Chang","year":"2009","unstructured":"Chang, M., Lee, A. J., Fitzpatrick, L., Zhang, M. & Sun, S. C. NF-\u03baB1 p105 regulates T cell homeostasis and prevents chronic inflammation. J. Immunol. 182, 3131\u20133138 (2009).","journal-title":"J. Immunol."},{"key":"28395_CR76","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.3748\/wjg.v29.i18.2733","volume":"29","author":"RF Souza","year":"2023","unstructured":"Souza, R. F., Caetano, M. A. F., Magalh\u00e3es, H. I. R. & Castelucci, P. Study of tumor necrosis factor receptor in the inflammatory bowel disease. World J. Gastroenterol. 29, 2733\u20132746 (2023).","journal-title":"World J. Gastroenterol."},{"key":"28395_CR77","doi-asserted-by":"crossref","unstructured":"De Giovanni, M. et al. Mast cells help organize the peyer\u2019s patch niche for induction of IgA responses. Sci Immunol 9, (2024).","DOI":"10.1126\/sciimmunol.adj7363"},{"key":"28395_CR78","doi-asserted-by":"crossref","unstructured":"Li, B. et al. Roles of the RANKL\u2013RANK axis in Immunity\u2014Implications for pathogenesis and treatment of bone metastasis. Front Immunol 13, (2022).","DOI":"10.3389\/fimmu.2022.824117"},{"key":"28395_CR79","doi-asserted-by":"crossref","unstructured":"Kobayashi, N., Takahashi, D., Takano, S., Kimura, S. & Hase, K. The roles of peyer\u2019s patches and microfold cells in the gut immune system: relevance to autoimmune diseases. Front Immunol 10, (2019).","DOI":"10.3389\/fimmu.2019.02345"},{"key":"28395_CR80","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41586-024-08284-1","volume":"637","author":"M Onji","year":"2025","unstructured":"Onji, M. et al. RANK drives structured intestinal epithelial expansion during pregnancy. Nature 637, 156\u2013166 (2025).","journal-title":"Nature"},{"key":"28395_CR81","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1128\/MCB.22.4.992-1000.2002","volume":"22","author":"J Mizukami","year":"2002","unstructured":"Mizukami, J. et al. Receptor activator of NF-kappaB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, tables 2, and TRAF6. Mol. Cell. Biol. 22, 992\u20131000 (2002).","journal-title":"Mol. Cell. Biol."},{"key":"28395_CR82","doi-asserted-by":"crossref","unstructured":"De Leon-Oliva, D. et al. The RANK-RANKL-OPG system: A multifaceted regulator of Homeostasis, Immunity, and cancer. Medicina (Kaunas) 59, (2023).","DOI":"10.3390\/medicina59101752"},{"key":"28395_CR83","unstructured":"Hildebrand, G. K., Patel, P. & Kasi, A. Denosumab. (2025)."},{"key":"28395_CR84","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S1074-7613(03)00326-1","volume":"19","author":"AJ Ashcroft","year":"2003","unstructured":"Ashcroft, A. J. et al. Colonic dendritic Cells, intestinal Inflammation, and T Cell-Mediated bone destruction are modulated by Recombinant osteoprotegerin. Immunity 19, 849\u2013861 (2003).","journal-title":"Immunity"},{"key":"28395_CR85","doi-asserted-by":"crossref","unstructured":"Yang, M., Zhu, L. & Osteoimmunology The crosstalk between T Cells, B Cells, and osteoclasts in rheumatoid arthritis. Int J. Mol. Sci 25, (2024).","DOI":"10.3390\/ijms25052688"},{"key":"28395_CR86","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1073\/pnas.1010030108","volume":"108","author":"A Yarilina","year":"2011","unstructured":"Yarilina, A., Xu, K., Chen, J. & Ivashkiv, L. B. TNF activates calcium\u2013nuclear factor of activated T cells (NFAT)c1 signaling pathways in human macrophages. Proc. Natl. Acad. Sci. 108, 1573\u20131578 (2011).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"28395_CR87","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/s41467-019-13883-y","volume":"11","author":"S Kimura","year":"2020","unstructured":"Kimura, S. et al. Osteoprotegerin-dependent M cell self-regulation balances gut infection and immunity. Nat. Commun. 11, 234 (2020).","journal-title":"Nat. Commun."},{"key":"28395_CR88","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cell.2019.11.014","volume":"180","author":"NY Lai","year":"2020","unstructured":"Lai, N. Y. et al. Gut-Innervating nociceptor neurons regulate peyer\u2019s patch microfold cells and SFB levels to mediate Salmonella host defense. Cell 180, 33\u201349e22 (2020).","journal-title":"Cell"},{"key":"28395_CR89","doi-asserted-by":"crossref","unstructured":"Veerasubramanian, P. K., Wynn, T. A., Quan, J. & Karlsson, F. J. Targeting TNF\/TNFR superfamilies in immune-mediated inflammatory diseases. Journal Experimental Medicine 221, (2024).","DOI":"10.1084\/jem.20240806"},{"key":"28395_CR90","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/s41590-021-00894-5","volume":"22","author":"A Prados","year":"2021","unstructured":"Prados, A. et al. Fibroblastic reticular cell lineage convergence in peyer\u2019s patches governs intestinal immunity. Nat. Immunol. 22, 510\u2013519 (2021).","journal-title":"Nat. Immunol."},{"key":"28395_CR91","first-page":"26","volume":"13","author":"M Blaschke","year":"2018","unstructured":"Blaschke, M. et al. Crohn\u2019s disease patient serum changes protein expression in a human mesenchymal stem cell model in a linear relationship to patients\u2019 disease stage and to bone mineral density. J. Clin. Transl Endocrinol. 13, 26\u201338 (2018).","journal-title":"J. Clin. Transl Endocrinol."},{"key":"28395_CR92","doi-asserted-by":"crossref","unstructured":"Papadaki, M. et al. New insights for RANKL as a Proinflammatory modulator in modeled inflammatory arthritis. Front Immunol 10, (2019).","DOI":"10.3389\/fimmu.2019.00097"},{"key":"28395_CR93","doi-asserted-by":"crossref","unstructured":"Glasnovi\u0107, A., O\u2019Mara, N., Kova\u010di\u0107, N., Gr\u010devi\u0107, D. & Gajovi\u0107, S. RANK\/RANKL\/OPG signaling in the brain: A systematic review of the literature. Front Neurol 11, (2020).","DOI":"10.3389\/fneur.2020.590480"},{"key":"28395_CR94","doi-asserted-by":"publisher","first-page":"16137","DOI":"10.1038\/s41598-025-99772-5","volume":"15","author":"CS Wu","year":"2025","unstructured":"Wu, C. S. et al. The alterations of molecular repertoire of the RANKL-induced osteoclastogenesis in the M1 macrophage-derived inflammatory milieu. Sci. Rep. 15, 16137 (2025).","journal-title":"Sci. Rep."},{"key":"28395_CR95","doi-asserted-by":"publisher","first-page":"W387","DOI":"10.1093\/nar\/gkad357","volume":"51","author":"C Bao","year":"2023","unstructured":"Bao, C. et al. OpenXGR: a web-server update for genomic summary data interpretation. Nucleic Acids Res. 51, W387\u2013W396 (2023).","journal-title":"Nucleic Acids Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28395-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28395-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28395-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:08:15Z","timestamp":1777388895000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28395-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":95,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["28395"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-28395-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"10 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This original article involved only the analysis of anonymized, publicly available data; ethical approval and informed consent were therefore not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"44713"}}